English | Español

Biospace
Patient Daily | Apr 16, 2026

FDA shows flexibility in rare disease drug trials amid evolving regulations
Patient Daily | Apr 16, 2026

Biopharma layoffs slow in early 2026 but job market remains uncertain
Patient Daily | Apr 16, 2026

BioSpace leaders discuss Q1 2026 job market trends and outlook
Patient Daily | Apr 16, 2026

Eli Lilly acquires CrossBridge Bio in $300 million deal for cancer drug development
Patient Daily | Apr 16, 2026

FDA urges over 2,200 drug developers to publish clinical trial results
Patient Daily | Apr 16, 2026

FDA approves Filspari as first treatment for rare kidney disease FSGS
Patient Daily | Apr 16, 2026

Patient-centric approach seen as key advantage in drug development, says Parexel executive
Patient Daily | Apr 16, 2026

Lilly announces major investments in China and Japan for oral GLP-1 production

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures